Ren et al. sequenced five nearly complete CRCoV genomes (30,852β30,893 nt) from nasal swabs of 15 respiratory-diseased puppies at a Chengdu veterinary teaching hospital (10/15 CRCoV-positive; 5 met RNA-quality criteria for NGS) . Phylogenetically, the strains form a distinct sub-branch clustering with Thai 2021β2022 strains (closest: D140NS, 99.5β99.7% identity) and are genetically distant from the earlier Chinese BJ232 lineage . No recombination was detected, though the authors concede the sparse global genome database limits this analysis.
Two unique non-coding deletions (4 nt and 8 nt) reduce predicted core promoter elements and binding stability β an interesting but purely in-silico regulatory hypothesis requiring experimental validation, which the authors themselves flag.
The sole prior pathogenicity study was over a decade old . Here, CRCoV CD1 was isolated in HCT-8 cells (106 TCID50/mL; only 1 of 10 positive samples yielded CPE), and intranasal challenge of three Beagles produced nasal discharge, sneezing, and coughing peaking at 6β9 DPI, with viral RNA highest in lung, and histopathology showing alveolar septal thickening and tracheal cilia loss . The authors honestly note lung-dominant tropism contradicts prior trachea/nasal-dominant findings and label the tropism-shift hypothesis as premature β commendable restraint.
Confidence: Genome sequencing, phylogeny, isolation, and clinical signs are well-supported (direct data, controls included). Docking-based functional claims and the tropism-shift hypothesis are low-confidence and falsifiable via reverse genetics and longitudinal tissue time-courses β precisely the validation the authors propose. What would change the conclusion: independent genomes contradicting the Thai clustering, or binding assays refuting the HE affinity gain.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.